Viewing nowCombinationAmloban Plus Tablet 5/80/5 mg
Amlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
Samchondang Pharmaceutical Co., Ltd.

MFDS item code 202106218 · Approved 2021.08.27 · Insurance code 651205770
Treatment of hypertension, improvement of dyslipidemia, and inhibition of atherosclerosis progression and cardiovascular disease risk
This medicine is used in patients with essential hypertension whose blood pressure is not well controlled by amlodipine and valsartan combination therapy, assisting in blood pressure management. Additionally, the rosuvastatin component aids in dietary treatment for patients with hypercholesterolemia and dyslipidemia, slows the progression of atherosclerosis, and reduces the risk of cardiovascular diseases. Specifically, rosuvastatin improves cardiovascular health by reducing the risk of stroke, myocardial infarction, and complications after arterial revascularization in high-risk groups. Therefore, this medicine is used to effectively reduce the risk of cardiovascular diseases through blood pressure and cholesterol management.
Take 1 tablet of this medicine once daily with water. It is recommended that it be taken at the same time each day, if possible (e.g., before breakfast). This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the amlodipine/valsartan combination and rosuvastatin. Patients taking an amlodipine/valsartan combination and rosuvastatin as separate products may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering the amlodipine/valsartan combination, it is recommended that the doses of the individual components (amlodipine or valsartan) be adjusted. However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to the amlodipine/valsartan combination may be considered as follows. ㆍ5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. ㆍ5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. ㆍ10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher). Do not administer the amlodipine/valsartan combination to patients with severe renal impairment (creatinine clearance below 10mL/min) or patients on dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan must not exceed 80mg. Do not administer the amlodipine/valsartan combination to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Use caution when increasing the dose. 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with rosuvastatin and continue it throughout treatment. Rosuvastatin may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to a maintenance dose. Most patients are controlled with a maintenance dose of 10 milligrams once daily. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, up to a maximum of 20 milligrams daily. 2. Elderly patients: No dosage adjustment is required. 3. Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering rosuvastatin 20mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or lower, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer rosuvastatin to patients with active liver disease. 5. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of rosuvastatin is contraindicated in some of these patients.
This medicine can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so use should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to the ingredients in this medicine, pregnant or breastfeeding women, and those with severe liver or kidney diseases should not take this medicine. Patients with low sodium or fluids in their body, hyperkalemia, vascular kidney problems, and those who have recently undergone kidney transplantation require special caution when taking this medicine and should do so under strict medical supervision. Patients with heart failure, myocardial infarction, aortic stenosis, or severe myasthenia gravis should also exercise caution when taking this medicine. During the use of this medicine, dizziness or fatigue may occur, so caution should be exercised when driving or operating machinery. This medicine can affect liver and kidney function, so patients with impaired liver or kidney function should consult a doctor before taking it. As this medicine lowers blood pressure, if symptoms of hypotension occur, the patient should be laid down and, if necessary, given intravenous fluids while monitoring until symptoms stabilize. Additionally, this medicine may cause muscle pain, muscle weakness, and, rarely, serious muscle damage (rhabdomyolysis), so if any muscle pain or weakness occurs, the patient should inform a doctor immediately. This medicine can interact with other medications, so if other medications are being taken, a doctor or pharmacist should be notified, especially when taking potassium supplements, diuretics, certain antibiotics, antifungals, or immunosuppressants. Pregnant or breastfeeding women should not take this medicine, and if planning to become pregnant, appropriate contraception should be used. Elderly individuals may respond sensitively to this medicine, so dosage adjustments and careful monitoring are necessary. In cases of overdose, serious hypotension, shock, heart function decline, etc., may occur, requiring immediate emergency treatment, and appropriate treatment should be followed as directed by a physician in case of overdose.
Peripheral edema, heat sensation, increased ALT, increased AST, increased serum creatinine, flank pain, neck pain, dizziness, sensory loss, nasopharyngitis, rash, nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, drowsiness, orthostatic dizziness, sensory abnormalities, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, erythema, sweating, rash, itching, joint edema, low back pain, arthritis, muscle cramps, lethargy, frequent urination, polyuria, erectile dysfunction, edema, localized edema, facial edema, fatigue, flushing, weakness, facial flushing, chest pain, pain, nocturia, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, hypercholesterolemia, hypoglycemia, urticaria, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremor, taste disturbance, peripheral neuropathy, hypertonia, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reactions, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urination disorders, nocturia, decrease in hemoglobin, decrease in hematocrit, neutropenia, thrombocytopenia, serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, vesicular dermatitis, myalgia, renal failure, kidney damage, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, intestinal vascular edema, polyneuropathy, amnesia, peripheral neuropathy, diarrhea, thrombocytopenia, jaundice, increased transaminases, eosinophilia, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, post-marketing cognitive impairment, severe myasthenia gravis, ocular myasthenia, weight loss, weight gain, pain, malaise, chest pain, increased serum creatinine, joint pain, fatigue, numbness, sensory abnormalities, chest discomfort, anorexia, abdominal bloating, abnormal liver function tests, diffuse pain, muscle cramps, gout
Not everyone experiences these, and they can vary from person to person.
This medicine may be sensitive to air and moisture, so it should be stored in a tightly closed container. Additionally, it should be stored at room temperature, ideally between 1 to 30 degrees Celsius, avoiding excessively hot or cold places.
Pale pink oval film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAmlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
Samchondang Pharmaceutical Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
HK Inno.N Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
HK Inno.N Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
HK Inno.N Co., Ltd.
Valsartan 80mg · Amlodipine Besylate 6.94mg +1 more
Tablet · Prescription medication · Combination
Kyungdong Pharm Co., Ltd.
Valsartan 160mg · Amlodipine Besylate 6.94mg +1 more
Tablet · Prescription medication · Combination
Kyungdong Pharmaceutical Co., Ltd.
Valsartan 160mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
Kyungdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.